The government on Friday said that Covaxin’s third phase trial data will be released by June 20. The new announcement came a day after Covaxin manufacturer Bharat Biotech said that the data will be made public by July.
Covaxin third-phase data and follow-up studies should be available in a few days,” Paul said during the press conference. Bharat Biotech has hinted that they will apply for full licensure of Covaxin when all the data is available to them. It is to be noted that the Phase-III data will be first submitted to the Central Drugs Standard Control Organisation (CDSCO), after which it will be published in peer-reviewed journals,the decision by the Drugs Controller General of India to give restricted emergency approval to Bharat Biotech’s Covaxin had raised questions over the transparency of the process. While the panel believed to have considered the phase-III data of Covishield’s UK trials, no such data of Phase-III trials were available for Covaxin.
